Sulfasalazine Tablet, Delayed Release
Product Images NDC 11534-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sulfasalazine (NDC 11534-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sunrise Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
Label for Sulfasalazine Delayed-Release Tablets, USP, 500 mg strength. The label indicates this is a bulk container of 100 tablets for oral use. The product is manufactured for Sunrise Pharmaceutical, Inc., Rahway, NJ. Instructions note dispensing in a well-closed container and storage at 25°C with excursions allowed. The label includes the product's NDC 11534-201-01 and cautions that it is not intended for household use.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
Label for Sulfasalazine Delayed-Release Tablets, USP 500 mg by Sunrise Pharmaceutical, Inc. The label indicates a 300 tablet bulk container with dosage strength prominently marked. It includes storage instructions, a barcode, and notes that it is Rx only and not intended for household use.*
FDA Label Image

Chemical Structure (Sulfasalazine 01)

Chemical Structure (Sulfasalazine 01)
Chemical structure of Sulfasalazine showing its molecular arrangement including a pyridine ring, sulfonamide group, azo linkage, and a benzoic acid moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.